戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 633781作成日:2026年10月26日

Dechloroclotrimazole → HCID 178508620、化合物

https://huagongshe.com/reaction/633781

反応式

関与物質

役割名称HCID仕込み量
反応物DechloroclotrimazoleHCID 618231—
反応物4-Iodo-1-tritylimidazoleHCID 618252—
反応物4-Amino-5-iodo-7-[2,3,5-tris-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidineHCID 131735476—
反応物HCID 178461630HCID 178461630—
触媒ZincchlorideHCID 3007855—
触媒HCID 178418397HCID 178418397—
溶媒ChloroformHCID 6212—
溶媒Trifluoroacetic acidHCID 6422—
溶媒TetrahydrofuranHCID 8028—
生成物HCID 178508620HCID 17850862077%

反応手順

To a solution of 4-iodo-1-trityl-1H-imidazole (609 mg, 1.4 mmol) in dry THF (6 ml) was added EtMgBr (1M in THF, 1.5 ml, 1.5 mmol) and the mixture was stirred at RT for 10 min. Then a solution of ZnCl2 (1M in THF, 2.8 ml, 2.8 mmol) was dropwise added and the mixture was stirred for 2 h. Resulting thick slurry was transferred to an argon purged mixture of 2′,3′,5′-tri-O-TBS-7-iodotubericidine {compound 4 from Example 17, Step 1} (515 mg, 0.7 mmol) and Pd(PPh3)4 (40 mg, 0.035 mmol) and the mixture was stirred at 90° C. for 16 h. The mixture was diluted with CHCl3 (20 ml) and washed with aq EDTA (sat., 20 ml). Aqueous layer was re-extracted with CHCl3 (2×5 ml). Collected organic extracts were dried over MgSO4, evaporated and chromatographed on silica (hexanes/AcOEt, 4:1→3:1) affording crude TBS,Tr-protected product contaminated by N-tritylimidazole. Crude product was deprotected by stirring in aq TFA (90% v/v, 2 ml) at RT for 18 h. The volatiles were removed in vacuo and the residue was several times co-evaporated with MeOH and finally loaded on silica by co-evaporation from MeOH. Column chromatography on silica (0→10% MeOH in CHCl3) afforded title compound 2r as white powder (179 mg, 77%). Compound was recrystallized from MeOH/water. Mp 276-278° C. [α]D −61.4 (c 0.249, DMSO). 1H NMR (500.0 MHz, DMSO-d6): 3.53 (ddd, 1H, Jgem=12.0, J5′b,OH=6.5, J5′b,4′=4.2, H-5′b); 3.64 (dd, 1H, Jgem=12.0, J5′a,OH=4.8, J5′a,4′=4.2, H-5′a); 3.89 (td, 1H, J4′,5′=4.2, J4′,3′=3.4, H-4′); 4.09 (ddd, 1H, J3′,2′=5.0, J3′,OH=4.8, J3′,4′=3.4, H-3′); 4.41 (ddd, 1H, J2′,OH=6.5, =6.3, J2′,3′=5.0, H-2′); 5.14 (d, 1H, JOH,3′=4.8, OH-3′); 5.30 (dd, 1H, JOH,5′=6.5, 4.8, OH-5′); 5.34 (d, 1H, JOH,2′=6.5, OH-5′); 6.03 (d, 1H, J1′,2′=6.3, H-1′); 7.14 (bs, 1H, NHaHb); 7.50 (d, 1H, J5,NH=2.0, J5,2=0.8, H-5-imidazole); 7.68 (s, 1H, H-6); 7.81 (d, 1H, J2,5=0.8, H-2-imidazole); 8.01 (s, 1H, H-2); 9.99 (bs, 1H, NHaHb); 12.31 (bs, 1H, NH-imidazole). 13C NMR (125.7 MHz, DMSO-d6): δ2.11 (CH2-5′); 70.87 (CH-3′); 73.76 (CH-2′); 85.23 (CH-4′); 87.30 (CH-1′); 100.77 (C-4a); 110.84 (C-5); 111.81 (CH-5-imidazole); 117.90 (CH-6); 134.95 (CH-2-imidazole); 135.10 (C-4-imidazole); 150.56 (C-7a); 152.08 (CH-2); 158.59 (C-4). MS (ESI) m/z 333 (M+H), 355 (M+Na). HRMS (ESI) for C14H17N6O4 [M+H] calcd: 333.1306. found: 333.1306. Anal. Calcd for C14H16N6O4: C, 50.60; H, 4.85; N, 25.29. Found: C, 50.55; H, 5.01; N, 24.28.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US09321800B2
出典データセットuspto-grants-2016_04
ORD IDord-fb5372173b2d42c593f9d3e8911864f5
出典メモuspto-grants-2016_04